About Queen Elizabeth II Health Sciences Centre; Gastroenterology Research
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
5
Clinical Trials at Queen Elizabeth II Health Sciences Centre; Gastroenterology Research
During the past decade, Queen Elizabeth II Health Sciences Centre; Gastroenterology Research conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on
average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors
2014-05-21
2020-04-16
Completed
609
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
2014-09-15
2025-08-16
Active, not recruiting
1,822
A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors
2014-08-12
2020-04-06
Completed
359
A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease
2015-03-20
2021-09-07
Completed
1,035
Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
2015-06-08
2026-05-21
Active, not recruiting
900
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Queen Elizabeth II Health Sciences Centre; Gastroenterology Research
According to Clinical.Site data, the most researched conditions in "Queen Elizabeth II Health Sciences Centre; Gastroenterology Research" are
"Crohn Disease" (2 trials), "Ulcerative Colitis" (2 trials) and "Colitis, Ulcerative" (1 trials). Many other conditions were trialed in "Queen Elizabeth II Health Sciences Centre; Gastroenterology Research" in a lesser frequency.
Clinical Trials Intervention Types at Queen Elizabeth II Health Sciences Centre; Gastroenterology Research
Most popular intervention types in "Queen Elizabeth II Health Sciences Centre; Gastroenterology Research" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Etrolizumab" (4 trials), "Placebo" (3 trials) and "Etrozulimab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Queen Elizabeth II Health Sciences Centre; Gastroenterology Research
The vast majority of trials in "Queen Elizabeth II Health Sciences Centre; Gastroenterology Research" are
5 trials for "All" genders.
Clinical Trials Status at Queen Elizabeth II Health Sciences Centre; Gastroenterology Research
Currently, there are NaN active trials in "Queen Elizabeth II Health Sciences Centre; Gastroenterology Research".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Queen Elizabeth II Health Sciences Centre; Gastroenterology Research,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Queen Elizabeth II Health Sciences Centre; Gastroenterology Research, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".